Inflammatory Pathway Suppression
NF-κB Inhibition
Reported to inhibit NF-κB and MAP-kinase signalling at nanomolar concentrations — the transcriptional step upstream of pro-inflammatory cytokine production, rather than the cytokines themselves.
- Inhibits NF-kB and MAP-kinase at nanomolar levels
- Reduces TNF-a, IL-6 and IL-1b
- Suppresses inflammatory output rather than raising anti-inflammatory signal








